ImmerseRx mNSCLC Immunotherapy Application icon

ImmerseRx mNSCLC Immunotherapy 1.0.0

1 MB / 0+ Downloads / Rating 5.0 - 1 reviews


See previous versions

ImmerseRx mNSCLC Immunotherapy, developed and published by Forefront Collab, has released its latest version, 1.0.0, on 2022-11-09. This app falls under the Medical category on the Google Play Store and has achieved over 10 installs. It currently holds an overall rating of 5.0, based on 1 reviews.

ImmerseRx mNSCLC Immunotherapy APK available on this page is compatible with all Android devices that meet the required specifications (Android 2.3+). It can also be installed on PC and Mac using an Android emulator such as Bluestacks, LDPlayer, and others.

Read More

App Screenshot

App Screenshot

App Details

Package name: com.forefront.mnsclcimmerserx

Updated: 2 years ago

Developer Name: Forefront Collab

Category: Medical

New features: Show more

Installation Instructions

This article outlines two straightforward methods for installing ImmerseRx mNSCLC Immunotherapy on PC Windows and Mac.

Using BlueStacks

  1. Download the APK/XAPK file from this page.
  2. Install BlueStacks by visiting http://bluestacks.com.
  3. Open the APK/XAPK file by double-clicking it. This action will launch BlueStacks and begin the application's installation. If the APK file does not automatically open with BlueStacks, right-click on it and select 'Open with...', then navigate to BlueStacks. Alternatively, you can drag-and-drop the APK file onto the BlueStacks home screen.
  4. Wait a few seconds for the installation to complete. Once done, the installed app will appear on the BlueStacks home screen. Click its icon to start using the application.

Using LDPlayer

  1. Download and install LDPlayer from https://www.ldplayer.net.
  2. Drag the APK/XAPK file directly into LDPlayer.

If you have any questions, please don't hesitate to contact us.

Previous Versions

ImmerseRx mNSCLC Immunotherapy 1.0.0
2022-11-09 / 1 MB / Android 2.3+

About this app

Powered by Forefront Collaborative, ImmerseRx mNSCLC Immunotherapy is an interactive learning tool that explores tumor immune evasion pathways in metastatic non-small cell lung cancer (mNSCLC), such as the programmed cell death protein 1 (PD-1)/programmed death-ligand 1 (PD-L1) pathway, and how immunotherapy targets these pathways to lead to tumor cell death. Moving through four interactive scenes, users will also learn about biomarker testing that is necessary to inform treatment decisions around immunotherapy for mNSCLC.

Pinch in and zoom out to scale, rotate, raise, or lower the models; and walk around the 3D objects to view animations up close. This app was created for medical oncologists, oncology nurse practitioners and physician assistants, pulmonologists, pathologists, and other healthcare professionals who are involved in the care of patients with mNSCLC.

This app is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc and Sanofi.

Note: after the creation of this app, additional immunotherapy combinations were approved as first-line treatment options for mNSCLC: cemiplimab plus platinum-based chemotherapy and tremelimumab plus durvalumab plus platinum-based chemotherapy.

New features

Initial release.